Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data
Generic Name : Imatinib
Indication : Newly diagnosed chronic myeloid leukaemia (CML). CML in blast crisis, accelerated phase or in chronic phase after failure of interferon-α therapy. Newly diagnosed/relapsed or refractory Philadel...
Manufacturer : Novartis
Distributor : Zuellig Pharma
Generic Name : Trastuzumab
Indication : Metastatic breast cancer (MBC) tumors that overexpress human epidermal growth factor receptor 2 (HER2) as monotherapy for patients who have received ≥1 chemotherapy regimens; in combination w/ pacl...
Manufacturer : Roche
Distributor : DKSH
Local Product Insert : Click to view
Generic Name : Trastuzumab
Indication : Metastatic breast cancer (MBC) who have tumors that overexpress HER2: Monotherapy for patients who have received ≥1 chemotherapy regimens for MBC. In combination w/ paclitaxel or docetaxel for pati...
Manufacturer : Celltrion Healthcare
Distributor : Zuellig Pharma
Generic Name : Palbociclib
Indication : Hormone receptor (HR) +ve, human epidermal growth factor receptor 2 (HER2) -ve locally advanced or metastatic breast cancer in combination w/ aromatase inhibitor as initial endocrine-based therapy in ...
Manufacturer : Pfizer
Distributor : Zuellig Pharma
Marketer : Pfizer
Generic Name : Ibrutinib
Indication : Adults w/ mantle cell lymphoma (MCL) who have received at least 1 prior therapy; chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL); CLL/SLL w/ 17p deletion; Waldenström's macrog...
Manufacturer : Janssen-Cilag
Distributor : DKSH
Generic Name : durvalumab
Indication : Monotherapy for locally advanced, unresectable NSCLC whose disease has not progressed following definitive platinum-based chemoradiation therapy. In combination w/ tremelimumab & platinum-based ch...
Manufacturer : AstraZeneca
Distributor : DKSH
Generic Name : Axitinib
Indication : Advanced renal cell carcinoma (RCC) after failure of 1 prior systemic therapy.
Manufacturer : Pfizer
Distributor : Zuellig Pharma
Generic Name : Ruxolitinib
Indication : Disease-related splenomegaly or symptoms in patients w/ high or intermediate risk myelofibrosis including primary myelofibrosis, post-polycythemia vera myelofibrosis or post-essential thrombocythemia ...
Manufacturer : Novartis
Distributor : Zuellig Pharma
Local Product Insert : Click to view

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in .
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in .
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in